Markus Wallwiener

机构：University Hospital in Halle, Martin Luther University Halle-Wittenberg · ORCID：0000-0002-4139-9340

发表论文 625 篇 · 总被引 40424 次 · h-index 53

代表论文

• Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis (2025 · Clinical Cancer Research · 被引 16)
• The IGF2BP1 oncogene is a druggable m6A-dependent enhancer of YAP1-driven gene expression in ovarian cancer (2025 · NAR Cancer · 被引 11)
• Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer (2025 · The Breast · 被引 7)
• Inhibition of RNA-binding proteins enhances immunotherapy in ovarian cancer (2025 · Signal Transduction and Targeted Therapy · 被引 6)
• Reconciling Sentinel Node Omission with CDK4/6 Inhibitor Eligibility in HR+/HER2- Early Breast Cancer: A Real-World Cohort Analysis (2025 · Clinical Breast Cancer · 被引 5)
• ChatGPT, Google, or PINK? Who Provides the Most Reliable Information on Side Effects of Systemic Therapy for Early Breast Cancer? (2024 · Clinics and Practice · 被引 5)